Thor Grundtvig Theander

Thor Grundtvig Theander

Professor

Member of:

    ORCID: 0000-0002-3509-7514

    Publication year:
    All
    1 - 3 out of 3Page size: 10
    1. 2014
    2. Published

      Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites

      Theander, Thor Grundtvig, Lusingu, J. P. A. & RTS,S Clinical Trials Partnership, R. C. T. P., Jul 2014, In: P L o S Medicine (Online). 11, 7, p. 1-24 24 p., e1001685.

      Research output: Contribution to journal › Journal article › peer-review

    3. Published

      Utilizing nanobody technology to target non-immunodominant domains of VAR2CSA

      Ditlev, S. B., Florea, R., Nielsen, Morten Agertoug, Theander, Thor Grundtvig, Magez, S., Boeuf, P. & Salanti, Ali, 21 Jan 2014, In: PLOS ONE. 9, 1, p. e84981

      Research output: Contribution to journal › Journal article › peer-review

    4. Published

      DNA secondary structures are associated with recombination in major Plasmodium falciparum variable surface antigen gene families

      Pedersen, A. F. S., Lavstsen, Thomas, Rask, T. S., Lisby, Michael, Salanti, Ali, Fordyce, S. L., Jespersen, Jakob Schmidt, Carter, R., Deitsch, K. W., Theander, Thor Grundtvig, Pedersen, A. G. & Arnot, D. E., 2014, In: Nucleic Acids Research. 42, 4, p. 2270-81 12 p.

      Research output: Contribution to journal › Journal article › peer-review

    ID: 11256